About
Rapid Myco develops a patented diagnostic technology using bacteriophage-based Phagomagnetic separation combined with qPCR for the rapid, sensitive, and specific detection of active mycobacterial infections in humans and commercial livestock.
Explore Rapid Myco's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.